Anti-ILT7 antibody

Details Anti-ILT7 antibody Anti-ILT7 antibody

2006-12-20

2011-12-27

Juedes, Amy (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C435S326000, C424S141100

Reexamination Certificate

active

08084585

ABSTRACT:
An antibody binding to IPC was obtained by using an animal cell in which a cell membrane protein associatable with ILT7 was co-expressed as an immunogen. The antibody of the invention has a high specificity which allows immunological distinction between other ILT family molecules and ILT7. The anti-ILT7 antibody of the invention bound to IPC and inhibited the activity thereof. With the anti-ILT7 antibody of the invention, the IPC activity can be inhibited and an interferon-related disease can be treated or prevented. ILT7 expression is maintained even in IPC in the presence of IFNα. Therefore, an inhibitory action of IPC activity by the anti-ILT7 antibody can be expected even in an autoimmune disease patient with an increased production of IFNα.

REFERENCES:
patent: 2003/0148316 (2003-08-01), Lipford et al.
patent: WO 03/012061 (2003-02-01), None
patent: WO 2004023973 (2004-03-01), None
Kameda et al., 1993, J. Histo and Cyto. vol. 41: 235-243.
Klimka et al., Brit. J. Canc. 2000, vol. 83: 252-260.
Blanco, P. et al., “Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus,”Science, Nov. 16, 2001, vol. 294, pp. 1540-1543.
Blasius, A. et al., “A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha,”Blood, Jun. 1, 2004, vol. 103(11):4201-4206.
Cao, W. et al., “Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production,”J. Exp. Med., Jun. 2006, vol. 203(6), pp. 1399-1405.
Colonna, M. et al., “A family of inhibitory and activating lg-like receptors that modulate function of lymphoid and myeloid cells,”Seminars in Immunology, 2000, vol. 12, pp. 121-127.
Hopkins & Meager, “Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon,”Clin. Exp. Immunol., 1988, vol. 73, pp. 88-92.
Ju, X. et al., “Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation,”Gene, 2004, vol. 331, pp. 159-164.
Kamogawa-Schifter, Y. et al., “Ly49Q defines 2 pDC subsets in mice,”Blood, 2005, vol. 105:2787-2792.
Nakajima, H. et al., “Cutting Edge: Human Myeloid Cells Express an Activating ILT Receptor (ILT1) That Associates with Fc Receptor gamma-Chain,”J. Immunol., 1999, vol. 162(1), pp. 5-8.
Nestle, F. et al., “Plasmacytoid predendritic cells initiate psoriasis through interferon-α production,”J. Exp. Med., Jul. 4, 2005, vol. 202(1):135-143.
Pérez, A. et al., “Myasthenia Gravis Induced by Alpha-Interferon Therapy,”Am J Hematol., Aug. 1995, vol. 49(4):365-366.
Shiozawa, S. et al., “Interferon-alpha in Lupus Psychosis,”Arthritis and Rheumatism, Apr. 1992, vol. 35(4):417-422.
Vales-Gomez, M. et al., “Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2,”Journal of Virology, Feb. 2005, vol. 79(4), pp. 2251-2260.
Wada, M. et al., “Antithyroid Peroxidase Antibody and Development of Silent Thyroiditis during Interferon-α2a Treatment of Chronic Hepatitis C,”Am J Gastroenterol. Aug. 1995, vol. 90(8):1366-1367.
Wilson, L. et al., “Autoimmune Disease Complicating Antiviral Therapy for Hepatitis C Virus Infection,”Seminars in Arthritis and Rheumatism, Dec. 2002, vol. 32(3):163-173.

Affiliated with

Also associated with

Rating

Anti-ILT7 antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-ILT7 antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-ILT7 antibody will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4256517